Home

V důchodu Vymýtit Pátý teva bloomberg park Vznášet se 945

Teva CEO Rejects Netanyahu Plea to Salvage Jerusalem Plant - Bloomberg
Teva CEO Rejects Netanyahu Plea to Salvage Jerusalem Plant - Bloomberg

Teva Prepared to Fight Charges in Generics Probe If Talks Fail - Bloomberg
Teva Prepared to Fight Charges in Generics Probe If Talks Fail - Bloomberg

Teva Pharmaceuticals to pay New York $523 million to settle claims from its  role in opioids crisis - ABC News
Teva Pharmaceuticals to pay New York $523 million to settle claims from its role in opioids crisis - ABC News

Teva Is Facing Adderall Supply Disruptions as Demand for ADHD Drug Soars -  Bloomberg
Teva Is Facing Adderall Supply Disruptions as Demand for ADHD Drug Soars - Bloomberg

Teva (TEVA) Agrees to $225 Million Texas Opioid Settlement, AG Says -  Bloomberg
Teva (TEVA) Agrees to $225 Million Texas Opioid Settlement, AG Says - Bloomberg

Teva's Adderall Shortage Seen Continuing Into March (TEVA) - Bloomberg
Teva's Adderall Shortage Seen Continuing Into March (TEVA) - Bloomberg

Adderall Shortages Spread to 4 Pharmaceutical Companies Including Teva,  Novartis - Bloomberg
Adderall Shortages Spread to 4 Pharmaceutical Companies Including Teva, Novartis - Bloomberg

Teva Is at Center of Drug Price-Fixing Case Filed by States - Bloomberg
Teva Is at Center of Drug Price-Fixing Case Filed by States - Bloomberg

Teva CEO Says Drugmaker Will Fight U.S. Price-Fixing Charges (2)
Teva CEO Says Drugmaker Will Fight U.S. Price-Fixing Charges (2)

Teva stock drops after conspiracy allegations on hiking drug prices
Teva stock drops after conspiracy allegations on hiking drug prices

Teva Generic Price-Fixing Securities Suit Gets Class Status (1)
Teva Generic Price-Fixing Securities Suit Gets Class Status (1)

Teva Pharmaceuticals found to be responsible for its role in the opioid  epidemic in New York State | CNN
Teva Pharmaceuticals found to be responsible for its role in the opioid epidemic in New York State | CNN

Teva CEO Vigodman Steps Down After Poor Outlook for 2017 | Fortune
Teva CEO Vigodman Steps Down After Poor Outlook for 2017 | Fortune

Teva flags supply constraints to ADHD drug Adderall as demand rises (NYSE: TEVA) | Seeking Alpha
Teva flags supply constraints to ADHD drug Adderall as demand rises (NYSE: TEVA) | Seeking Alpha

Teva makes $40.1 billion takeover bid for Mylan | Mint
Teva makes $40.1 billion takeover bid for Mylan | Mint

Teva Pharmaceutical Will Pay Over $4 Billion in Opioid Settlement -  Bloomberg
Teva Pharmaceutical Will Pay Over $4 Billion in Opioid Settlement - Bloomberg

Activist Investor Jana Partners Takes Stake in Teva, Report Says | Ctech
Activist Investor Jana Partners Takes Stake in Teva, Report Says | Ctech

Teva to Sell Record $5 Billion of Sustainability-Linked Bonds - BNN  Bloomberg
Teva to Sell Record $5 Billion of Sustainability-Linked Bonds - BNN Bloomberg

Teva Analysts Say Migraine Drug Approval Gives Needed Relief - Bloomberg
Teva Analysts Say Migraine Drug Approval Gives Needed Relief - Bloomberg

Teva Shows Progress on Restructuring But Investors Want More - TheStreet
Teva Shows Progress on Restructuring But Investors Want More - TheStreet

Teva Is 'on the Way' to Leaving Opioid Litigation Behind, CEO Says |  Barron's
Teva Is 'on the Way' to Leaving Opioid Litigation Behind, CEO Says | Barron's

Teva Pharmaceutical to Replace CEO Kare Schultz - WSJ
Teva Pharmaceutical to Replace CEO Kare Schultz - WSJ

Teva to Pay $85 Million Settlement in Oklahoma Opioid Case - Bloomberg
Teva to Pay $85 Million Settlement in Oklahoma Opioid Case - Bloomberg

Teva Pharma's Short Sellers Double Down as Legal Woes Drag On - Bloomberg
Teva Pharma's Short Sellers Double Down as Legal Woes Drag On - Bloomberg

Actavis CEO: Teva-Mylan deal could be "value-destroying" - Globes
Actavis CEO: Teva-Mylan deal could be "value-destroying" - Globes

Teva Sees Adderall Supply Delays Continuing for 2-3 Months (1)
Teva Sees Adderall Supply Delays Continuing for 2-3 Months (1)

A bottle of Teva Pharmaceutical Industries Ltd. Clonazepam medication...  News Photo - Getty Images
A bottle of Teva Pharmaceutical Industries Ltd. Clonazepam medication... News Photo - Getty Images

Teva shares plummet amid CEO departure and bribery reports
Teva shares plummet amid CEO departure and bribery reports